Retatrutide Study Explores Effects on Obesity and Related Conditions | Retatrutide News

The completed trial evaluated the efficacy and safety of retatrutide in obesity and related conditions. It lasted about 89 weeks and included subsets wi...
Clinical Trials · October 24, 2026